|
⚲
|
| Milind Deshpande | |
|---|---|
| Firm | |
| Address | c/o Avilar Therapeutics, Inc 400 Totten Pond Road, Suite 110 Waltham, Ma 02451 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Spero Therapeutics Inc | 021-464777 | Director | 9.0 M of 9.0 M |
||
| Triana Biomedicines Inc | 021-433414 | Director | 42.6 M of 85.1 M |
||
| Santi Therapeutics Inc | 021-413815 | Executive Officer | 10.0 M of 10.0 M |
||
| Spero Therapeutics Inc | 021-406258 | Director | 40.0 M of 40.0 M |
||
| Avilar Therapeutics Inc | 021-383553 | Director | 75.3 M of 75.3 M |
||
| Santi Therapeutics Inc | 021-370304 | Executive Officer | 6.0 M of 14.0 M |
||
| Nayan Therapeutics Inc | 021-332794 | Executive Officer | 3.0 M of 25.0 M |
||
| Spero Therapeutics LLC | 021-283010 | Director | 43.2 M of 43.2 M |
||
| Achillion Pharmaceuticals Inc | 021-146800 | Executive Officer | 50.1 M of 50.1 M |
||